Jay Bradner, president of the Novartis Institutes for Biomedical Research (NIBR), is retiring from the position after seven years in the role, and will be replaced by Merck & Co R&D
Long-serving Roche chief executive Severin Schwan is stepping down, to be replaced next March by Thomas Schinecker, currently head of diagnostics at the Swiss group.
UK health secretary Sajid Javid is giving up his position after a year in the role, saying in his resignation letter that he can "no longer, in good conscience, continue serving in this gov
A Swiss newspaper has said Novartis' previously announced restructuring programme could lead to 8,000 axed jobs, including up to 1,400 at its home base in Switzerland.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.